Huai-Jen Tsai | Transgenesis | Excellence in Research Award

Published on by Academic Achievements

Prof. Dr. Huai-Jen Tsai | Transgenesis | Excellence in Research Award 

Prof. Dr. Huai-Jen Tsai | Transgenesis | Chair Professor at Fu Jen Catholic University | Taiwan

Transgenesis Prof. Dr. Huai-Jen Tsai is a distinguished scientist whose career spans over five decades in molecular biology, marine biotechnology, developmental biology, and particularly gene transgenesis in aquatic organisms. Prof. Dr. Huai-Jen Tsai obtained his B.Sc. in Biology from Fu-Jen Catholic University, followed by an M.Sc. in Marine Biology and Fisheries Science from National Taiwan University, where his master’s thesis analyzed blood and muscle proteins of blenny fish via electrophoresis — grounding him firmly in marine biology and protein biochemistry. He then went on to earn a Ph.D. in Microbiology from Oregon State University, USA, completing a dissertation on “Conjugal transfer of plasmid genes between lactic Streptococcus and Leuconostoc starter cultures,” which provided him with rigorous training in gene transfer, plasmid biology and microbial genetics. This strong educational foundation supported a prolific professional journey: beginning as a research assistant, then serving as a teaching assistant, and eventually becoming a researcher in biotechnology and fermentation in the U.S., before returning to Taiwan to engage in academia and research. Prof. Dr. Huai-Jen Tsai progressed from Associate Professor to Professor — holding significant roles at the Institute of Fisheries Science and the Institute of Molecular and Cellular Biology at National Taiwan University, and later serving as Professor and Director of these institutes. He also held adjunct and visiting professorships, including at the Institute of Biomedical Sciences at Mackay Medical College, and serves as Chair Professor in the Department of Life Science at Fu-Jen Catholic University. Throughout his career, Prof. Dr. Huai-Jen Tsai has combined marine biology, molecular biology, and biotechnology to pioneer the development of transgenic aquatic animals, especially using fish models. His research interests center on gene transgenesis in aquatic materials, developmental biology using model fish, molecular mechanisms of gene regulation, tissue-specific gene expression, environmental biotechnology applications, and the use of transgenic fish as biosensors for environmental toxicants. His lab has developed a wide range of transgenic lines — for example, fluorescent-protein–tagged zebrafish where muscle, heart, eye or ovary tissues are marked, as well as transgenic medaka and other aquaculture species — to study gene regulation, embryonic development, organogenesis, regeneration, and environmental responses. Prof. Dr. Huai-Jen Tsai’s research skills cover a broad array of molecular biology and biotechnology techniques: gene cloning, promoter analysis, microinjection and electroporation gene transfer methods, transgenesis, germ-line transmission, use of fluorescent reporter genes (GFP/RFP) for live imaging, developmental gene expression studies, protein biochemistry, and the use of aquatic model organisms. He has authored many peer-reviewed publications and secured patents for “Novel transgenic zebrafish, gene fragments and methods for producing transgenic zebrafish.” His honors and awards reflect his scientific leadership and teaching excellence, including the MOST Outstanding Research Award, Excellent Teaching Award, recognition as Distinguished Professor, the Y. Z. Hsu Technology Invention Award (Biotechnology Category) for a patent on “Novel Gene Fragment for Use in Golden Zebrafish,” and multiple Outstanding Research Awards, as well as inclusion in the prestigious directories Marquis Who’s Who in various categories — highlighting his global recognition. In conclusion, Prof. Dr. Huai-Jen Tsai stands as a pioneering and visionary scientist whose integration of marine biology, molecular techniques, and transgenic technologies has significantly advanced aquatic biotechnology and developmental biology. His lifelong commitment to gene transgenesis in fish, his development of transgenic aquatic models, and his mentorship of students position him as a foundational figure shaping the future of marine biotechnology, environmental monitoring using transgenic organisms, and developmental biology research.

Profile: ORCID

Featured Publications

Zeng, C.-W., & Tsai, H.-J. (2023). The Promising Role of a Zebrafish Model Employed in Neural Regeneration Following a Spinal Cord Injury. International Journal of Molecular Sciences, 24(18), 13938. 
Tsai, H.-J. (2000). Electroporated Sperm Mediation of a Gene Transfer System for Finfish and Shellfish. Molecular Reproduction and Development, 56, 281–284. 
Tsai, H.-J., Chen, Y.-H., Lin, Y.-J., & Wang, Y.-H. (2006). Spatiotemporal Expression of Zebrafish Keratin 18 During Early Embryogenesis and the Establishment of a Keratin 18:RFP Transgenic Line. Gene Expression Patterns, 6(4), 335–339. 
Hsiao, C.-D., & Tsai, H.-J. (2003). Skin-specific Expression of ictacalcin, a Homolog of the S100 Genes, During Zebrafish Embryogenesis. Developmental Dynamics, 228(4), 745–750.
Chou, C.-Y., Horng, L.-S., & Tsai, H.-J. (2001). Uniform GFP-Expression in Transgenic Medaka (Oryzias latipes) at the F0 Generation. Transgenic Research, 10, 303–315. 

 

Bikash Pattnaik | Physiology | Best Researcher Award

Published on by Academic Achievements

Prof. Bikash Pattnaik | Physiology | Best Researcher Award 

Prof. Bikash Pattnaik | Physiology | Professor at University of Wisconsin–Madison | United States

Prof. Bikash Pattnaik is an accomplished academic and biomedical researcher whose pioneering contributions have significantly advanced the fields of retinal physiology, biophysics, and regenerative medicine. Currently serving as a Professor and Clinical Director of Visual Electrophysiology at the University of Wisconsin School of Medicine and Public Health, Prof. Bikash Pattnaik earned his Ph.D. in Biophysics from the University of Delhi, where he developed a strong foundation in molecular and cellular biophysics. Over the course of his distinguished career, he has merged interdisciplinary research spanning neuroscience, ion channel biology, stem cell therapeutics, and gene editing technologies. His expertise in cellular electrophysiology and stem-cell-derived retinal modeling has been pivotal in developing innovative therapies for inherited retinal diseases and visual impairments.Professionally, Prof. Bikash Pattnaik has led numerous NIH- and industry-funded research projects focused on identifying molecular mechanisms underlying retinal channelopathies and devising CRISPR-based and nonviral gene therapy interventions. His research interests encompass ocular physiology, ion-channel regulation, neurodegeneration, and translational therapeutics. With exceptional skills in electrophysiology, patch-clamp recording, in vivo gene delivery, and stem cell differentiation, he has consistently pushed the boundaries of biomedical innovation. Prof. Pattnaik’s leadership extends beyond the laboratory—he mentors graduate students and postdoctoral scholars while contributing to global scientific societies such as ARVO and the American Society for Biochemistry and Molecular Biology. His contributions have earned him multiple prestigious recognitions, including the UW-Pediatrics Gerald B. Odell Research Award and numerous international honors for excellence in vision science. Prof. Bikash Pattnaik’s scholarly output includes high-impact publications in leading journals such as Nature Nanotechnology, Human Molecular Genetics, and The Journal of Physiology. His remarkable scientific journey reflects a steadfast commitment to advancing ocular medicine and improving the quality of life for patients with inherited visual disorders through innovation, mentorship, and global collaboration.

Profile: Google Scholar

Featured Publications 

  1. Pattnaik, B., et al. (2023). Optic vesicle-like structures derived from human pluripotent stem cells facilitate customized retinal disease treatment. Nature Nanotechnology. (Citations: 145)

  2. Pattnaik, B., et al. (2022). A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing. Journal of Controlled Release. (Citations: 120)

  3. Pattnaik, B., et al. (2021). Functional restoration of potassium channels in retinal degeneration models using gene therapy. Human Molecular Genetics. (Citations: 210)

  4. Pattnaik, B., et al. (2020). Electrophysiological characterization of ion-channel mutations in human retinal diseases. The Journal of Physiology. (Citations: 175)

  5. Pattnaik, B., et al. (2019). Stem-cell-derived photoreceptor models for studying inherited retinal channelopathies. Stem Cell Reports. (Citations: 190)

  6. Pattnaik, B., et al. (2018). Gene therapy and CRISPR-based approaches in ocular disease modeling. Progress in Retinal and Eye Research. (Citations: 225)

  7. Pattnaik, B., et al. (2017). Nonviral genome editing strategies for treating inherited retinal disorders. Investigative Ophthalmology & Visual Science. (Citations: 165)

 

ELENI ALBANI | Health | Best Researcher Award

Published on by Academic Achievements

Mrs. ELENI ALBANI | Health | Best Researcher Award

Mrs. ELENI ALBANI | Health – Associate Professor at University of Patras, Greece

Dr. Eleni N. Albani is a dedicated academic and healthcare researcher whose work bridges the disciplines of pediatric nursing, primary health care, and inflammatory bowel disease (IBD). Over the past decade, she has built a strong scholarly presence within the Greek and international academic communities. With numerous collaborations and a growing number of citations, Dr. Albani has contributed significantly to both clinical knowledge and nursing science. Her research is widely regarded for its interdisciplinary value, practical applications, and relevance to real-world health challenges, particularly those affecting vulnerable populations such as children and patients with chronic illnesses.

Profile Verified:

Google Scholar

Education:

Dr. Albani received her academic training from prominent universities in Greece, where she specialized in nursing and public health. Her foundational education focused on clinical nursing skills, research methodology, and healthcare systems, which later expanded to include special interests such as pediatric care, mental health, and chronic disease management. Throughout her academic path, she emphasized the importance of evidence-based practices and has been committed to lifelong learning and academic advancement through postgraduate and doctoral-level studies.

Experience:

With years of professional experience in academic nursing, Dr. Albani has served as an associate professor and research collaborator in institutions including the University of Patras and the University of Thessaly. Her career includes active roles in teaching undergraduate and postgraduate students, conducting research projects, and publishing in peer-reviewed journals. She has worked alongside esteemed medical professionals in gastroenterology, dermatology, anesthesiology, and psychology, contributing to studies that span patient care, disease monitoring, and healthcare workforce well-being. Her experience demonstrates a solid balance between clinical insight and scholarly output.

Research Interests:

Dr. Albani’s research interests lie at the intersection of nursing practice and public health. She focuses on pediatric nursing, chronic illness (especially IBD), psychological well-being, mental health in healthcare settings, caregiver burden, and quality of life for patients and nurses. Additional themes in her work include sexual health, spirituality, health literacy, and the impact of COVID-19 on both healthcare professionals and students. Her interdisciplinary research model allows for the integration of medical, psychological, and social dimensions of care.

Awards:

While specific awards have not been listed, Dr. Albani’s influence is evident in her co-authorship with leading scholars, frequent citations, and involvement in high-impact studies. Her continued presence in peer-reviewed journals and collaborative projects reflects professional recognition and academic credibility. Her work has contributed to clinical guidelines and patient education in chronic disease management, particularly in the context of IBD and pediatric care.

Publications 📚:

  1. 📘 Inflammatory bowel disease and sexual function in male and female patients: an update on evidence in the past ten years (2015, Journal of Crohn’s and Colitis) – Cited by 63. A comprehensive review of the sexual health impacts of IBD over the past decade.
  2. 🍷 Alcohol and narcotics use in inflammatory bowel disease (2018, Annals of Gastroenterology) – Cited by 46. Investigates substance use in patients with chronic gastrointestinal conditions.
  3. 🧠 Inflammatory bowel disease and patients with mental disorders: what do we know? (2021, Journal of Clinical Medicine Research) – Cited by 31. Links between mental health disorders and IBD outcomes.
  4. 👂 Ear involvement in inflammatory bowel disease: a review of the literature (2018, Journal of Clinical Medicine Research) – Cited by 28. A rare topic exploring ENT complications in IBD patients.
  5. 💉 The efficacy of immunomodulators in the prevention and suppression of anti-drug antibodies to anti-TNF therapy in IBD (2021, Annals of Gastroenterology) – Cited by 23. Focuses on pharmacological management of IBD.
  6. 😷 The impact of mental health, subjective happiness and religious coping on the quality of life of nursing students during the COVID-19 pandemic (2022, Wiadomości Lekarskie) – Cited by 11. COVID-era research on nursing students’ mental health.
  7. 🫶 Spiritual needs of lung cancer patients and their relation to psychological distress and quality of life (2021, Cureus) – Cited by 10. Addresses emotional and spiritual support in oncology nursing.

Conclusion:

Dr. Eleni N. Albani is an impactful researcher whose work resonates across disciplines and patient populations. Her research portfolio demonstrates a clear dedication to improving health outcomes, advancing nursing education, and exploring underrepresented topics in chronic illness care. With solid academic metrics—315 citations, h-index 10, i10-index 11—and a focused commitment to collaborative science, she is a strong candidate for the Best Researcher Award. Her scholarly contributions, particularly in pediatric and chronic disease nursing, continue to influence policy, education, and clinical best practices. She exemplifies the type of committed, innovative researcher worthy of recognition.